Skip to content
OpenCapital
Get started

4D Molecular Therapeutics FDMT Market capitalization

Market capitalization at other companies

Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$113.44B-8.9%
EyePoint, Inc. logo
EyePoint, Inc. EYPT
$1.08B+189%
AbbVie logo
AbbVieABBV
$384.69B+3.8%
Regenxbio logo
RegenxbioRGNX
$432.52M+20.8%

Other financials

Income statement

See full
Revenue$3.0M+21,664%
Operating income-$73.6M-37.3%
Net income-$68.8M-43.3%
EPS (diluted)-$1.01-17.4%

Balance sheet

See full
Cash & equivalents$72.5M-45.7%
Total debt$20.5M-13.9%
Total equity$451.8M-3.8%
Total assets$512.9M-0.5%

Cash flow

See full
Operating cash flow-$68.1M-42.6%
CapEx--100%
Free cash flow-$68.1M-40.8%

Valuation

See full
Enterprise value$550.27M+574%
P/S6.8×-8,306×

Profitability

See full
Operating margin-220.1%-110pp
Net margin-174,314.2%-62,763pp
FCF margin-154,209.2%-53,057pp

Returns & leverage

See full
Return on equity-45.4%+29.8pp
Debt / equity0×0.0×
Current ratio9.3×-3.0×

Where this comes from

Computed from the period-end share price: $475.29M.

The official record: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about 4D Molecular Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 4D Molecular Therapeutics's market capitalization?
4D Molecular Therapeutics (FDMT) reported market capitalization of $475.29M in Q1 2026.
How has 4D Molecular Therapeutics's market capitalization changed year-over-year?
4D Molecular Therapeutics's market capitalization increased by 217.8% year-over-year, from $149.56M to $475.29M.
What is the long-term trend for 4D Molecular Therapeutics's market capitalization?
Over 5 years (2020 to 2025), 4D Molecular Therapeutics's market capitalization has grown at a -17.3% compound annual growth rate (CAGR), from $1.11B to $428.51M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.